Why Choose Mount Sinai for Interventional Cardiology/Cardiac Catheterization

Led by Samin K. Sharma, MD, and Annapoorna S. Kini, MD, The Mount Sinai Hospital's Cardiac Catheterization Laboratory is the nation's best and busiest. Comprised of some of the world's most experienced cardiologists, our Cardiac Cath Lab offers expert diagnosis, state-of-the-art technology, and unparalleled excellence in care and patient safety. It has achieved the highest safety rating among New York State's 61 institutions that perform percutaneous coronary interventions (PCI), a minimally invasive heart procedure commonly known as angioplasty. No other hospital has matched this level of patient safety rating for both emergency and non-emergency cases since public reporting of PCI results began in 1994, per the New York State Department of Health.

The Cardiac Catheterization Laboratory of Mount Sinai Heart at The Mount Sinai Hospital made history by being the first hospital in New York State ever to have three of its interventional cardiologists receive the highest "two-star" safety rating from the New York State Department of Health for its percutaneous coronary interventions (PCI), according to the latest report.

Drs. Samin Sharma, Annapoorna Kini, and George Dangas were each awarded the highest two-star safety rating for PCI’s, while performing a total of 7247 PCI cases. Dr. Sharma was the only one of two interventional cardiologists in New York State to receive the highest two-star safety rating in two categories of both non-emergency and emergency cases.

This marks the 18th consecutive year the Mount Sinai Catheterization Laboratory or its physicians have been awarded a prestigious two-star designation for safety rates significantly exceeding the statewide average.

Mount Sinai's multidisciplinary interventional cardiology team, patient volume, and procedural offerings have expanded significantly, as the Cath Lab has performed more than 5,000 interventions per year for the last five years. This upward momentum has also drawn an increase in complex cases, which have become a hallmark of our Cath Lab. Stable interventional growth with declining complications - despite increasing complexity of cases - has been achieved at Mount Sinai Heart through seamless teamwork and dedication to treating each individual patient, taking into account his or her medical history, type and status of condition and lifestyle.

Excellence in Full Range of Interventional Cardiology Procedures

Patients ranging from pediatrics to geriatrics come to Mount Sinai's Catheterization Laboratory from all over the world for interventional procedures to help restore the pathway to the heart. This includes routine diagnostics and procedures such as angioplasties, catheterizations and stents (including drug-eluting stents) to the full spectrum of techniques for complex cases. Our team is internationally recognized for our vast expertise in the following complex procedures:

  • CABG (coronary artery bypass graft)
  • Rotational atherectomy
  • TAVI/TAVR (transcatheter aortic valve implementation/replacement)
  • PCI for CTO (chronic total occlusion, or chronic blockage)
  • Left main stenting for unprotected left main coronary artery (LMCA) disease
  • Balloon valvuloplasty: aortic and mitral

Multidisciplinary Cardiac Catheterization Team

The Cath Lab's multidisciplinary team of interventionalists, nurses, technicians and support staff is committed to continuous quality improvement and providing excellent patient care. Constant communication and adherence of protocols have enabled our team to achieve an unprecedented level of patient safety. Additionally, world-class research physicians have recently joined the team to further our research studies of the underlying causes of heart disease and develop targeted tools and procedures to treat its many permutations.